Early trial tests Next-Gen cell therapy for tough blood cancers
NCT ID NCT07240974
Summary
This is a very early study to test the safety and initial effects of a new cell therapy called ZZSW-01. It is for adults with advanced B-cell blood cancers, like certain lymphomas and leukemias, that have come back or not responded to standard treatments. The main goals are to find a safe dose and see if the therapy shows any signs of helping to control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY B-CELL MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, 430022, China
Conditions
Explore the condition pages connected to this study.